STXBP1 Encephalopathy With Epilepsy Clinical Trial
Official title:
Phenotyping and Identification of Biological Markers in STXBP1 Encephalopathy
This is a prospective observational study to evaluate the phenotype of 10 patients under 10 years of age with developmental epileptic encephalopathy due to mutation of the STXBP1 gene. The study will consist of a clinical and neurodevelopmental evaluation, magnetic resonance imaging, prolonged electroencephalogram, cardiological study, and analysis of biomarkers in cerebrospinal fluid. These patients will be followed up for 3 years. The aim of the study is, knowing the baseline phenotype, to analyse the response to commonly used drugs and to anticipate the response to different drugs available on the market in this group of patients based on clinical and biomarker assessment (EEG, MRI and study of specific proteins and neurotransmitters in plasma, urine and CSF).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT01238250 -
Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight
|
||
| Recruiting |
NCT05232630 -
Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes
|
Phase 4 | |
| Not yet recruiting |
NCT05462054 -
Natural History Study in Pediatric Patients With STXBP1 Encephalopathy With Epilepsy
|
||
| Recruiting |
NCT05161494 -
Gait in Rare Diseases
|